‘Inflammatory Bowel Disease• The results of the first cohort of patients from the randomized, controlled study of remestemcel-L by direct endoscopic delivery to areas of inflammation in patients with medically refractory ulcerative colitis or Crohn’s colitis were presented at the 17th Congress of European Crohn’s and Colitis Organisation (ECCO) by the trial’s lead investigator Dr. Amy L. Lightner, Associate Professor of Surgery in the Department of Colon and Rectal Surgery at Cleveland Clinic• Results from an interim analysis of the first twelve patient cohort were published in the Journal of Crohn's and Colitis.2,3 A single local delivery of remestemcel-L by colonoscopy resulted in rapid mucosal healing, improved clinical and endoscopic scores as early as two weeks following remestemcel-L, and a high incidence of disease remission by six weeks. Dr. Lightner is scheduled to present results from additional patients at the world’s premier meeting for physicians, researchers and industry professionals in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery, Digestive Disease Week® (DDW) next month’
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-13394
-
- There are more pages in this discussion • 4,624 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.02 |
Change
0.005(0.50%) |
Mkt cap ! $1.158B |
Open | High | Low | Value | Volume |
$1.02 | $1.02 | $1.00 | $1.192M | 1.182M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
27 | 154631 | $1.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.02 | 36481 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
28 | 156491 | 1.010 |
16 | 102452 | 1.005 |
15 | 142729 | 1.000 |
9 | 211867 | 0.995 |
10 | 573404 | 0.990 |
Price($) | Vol. | No. |
---|---|---|
1.015 | 37629 | 13 |
1.020 | 223939 | 20 |
1.025 | 107897 | 9 |
1.030 | 76500 | 7 |
1.035 | 78950 | 4 |
Last trade - 13.45pm 19/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |